Weight-loss drugs have been available on the UK’s NHS for some time.
But the landscape changed significantly with the introduction of some newer medications – among them, semaglutide, marketed under the brand name Wegovy, and tirzepatide, sold as Mounjaro.
They work in part as an appetite suppressant by mimicking a hormone, which makes people feel fuller, and studies have suggested patients can lose as much as a fifth of their body weight.
An estimated 1.5 million people in the UK use these drugs – but more than nine in 10 are believed to pay privately.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#BBCNews
